Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-010094
Filing Date
2022-04-15
Accepted
2022-04-15 16:26:47
Documents
80
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3561464
2 ex23-1.htm EX-23.1 3292
3 ex23-2.htm EX-23.2 3419
4 ex31-1.htm EX-31.1 12462
5 ex31-2.htm EX-31.2 11767
6 ex32-1.htm EX-32.1 4191
7 ex32-2.htm EX-32.2 4174
  Complete submission text file 0001493152-22-010094.txt   12804109

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT otlc-20211231.xsd EX-101.SCH 74753
9 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT otlc-20211231_cal.xml EX-101.CAL 63897
10 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT otlc-20211231_def.xml EX-101.DEF 439234
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT otlc-20211231_lab.xml EX-101.LAB 584886
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT otlc-20211231_pre.xml EX-101.PRE 529790
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2064243
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 22830270
SIC: 2834 Pharmaceutical Preparations